Is Capnometry Monitoring Useful in Nonintubated Neonates?  by Lin, Yuh-Jyh
©2010 Taiwan Pediatric Association
EDITORIAL
Pediatr Neonatol 2010;51(6):309−310
Corresponding author. Department of Pediatrics, National Cheng-Kung University Hospital, 138 Sheng-Li Road, Tainan, Taiwan.
E-mail: lin.yuhjyh@gmail.com
Maintenance of normal PaCO2 may prevent mor-
bidity due to an overly high or low PaCO2 level. 
High PaCO2 level or hypercarbia may increase cer-
ebral blood flow and the risk of developing intra-
ventricular hemorrhage.1,2 On the other hand, low 
PaCO2 level or hypocarbia may increase the incidence 
of periventricular leukomalacia and chronic lung 
disease.3,4 Maintaining normocarbia in neonate re-
quires frequent arterial blood gas analysis, which are 
associated with complications such as arterial spasm, 
ischemia, infection and pain.5 Other methods for 
determining carbon dioxide are therefore desirable 
and include end tidal carbon dioxide (ETCO2), cap-
illary sampling, and transcutaneous CO2 monitoring.5
Continuous ETCO2 detectors or capnometers 
measure exhaled CO2 and display a numerical value 
of CO2 tension in mmHg or % CO2.6 Capnometers 
use two different sampling techniques: side-stream 
and mainstream sampling. A mainstream capnom-
eter has an airway detector attached in-line and 
close to the endotracheal tube. The detector in-
corporates an infrared light source and sensor that 
senses CO2 absorption to measure the partial pres-
sure of CO2 (PaCO2). This method is more accurate 
than side-stream sampling. A side-stream capnom-
eter uses a sampling line that attaches to a T-piece 
adapter at the airway opening, through which the 
instrument continually aspirates airway gas for 
analysis of CO2.7 Continuous ETCO2 monitoring is 
widely accepted and used in adult and pediatric 
patients. Greer et al8 reported that tidal volume, 
through its effect on dead space to tidal volume 
ratios and arterial-alveolar CO2 differences, has a 
significant effect on PetCO2. In their study, lower 
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PetCO2 levels were observed when tidal volume was 
either too low or too high.8 In neonates, small tidal 
volume, higher respiratory rate with short expira-
tory time could result in a lack of true alveolar gas 
being measured and demonstrate wide variations 
in PetCO2 levels.9 In intubated neonates, McEvedy 
et al10 reported that distal sidestream PetCO2 and 
mainstream PetCO2 correlated well with PaCO2. 
However, proximal sidestream PetCO2 correlated 
very poorly with PaCO2. Several studies also dem-
onstrated that monitoring PetCO2 via nasal cannula 
may provide a useful estimate of PaCO2 in nonintu-
bated pediatric patients.11−14
In this issue of Pediatrics and Neonatology, Tai 
et al15 utilized a side-stream capnometry to measure 
end-tidal carbon dioxide via nasal cannula in non-
intubated neonates. They found that there was a 
good correlation between PetCO2 and PaCO2 levels 
among 54 paired samples. In addition, they also 
found the difference between PetCO2 and PaCO2 
levels was significant only among those with respira-
tory disease, but not among those without it. The-
oretically, the more severe the ventilation-perfusion 
mismatch, the higher the difference between PetCO2 
and PaCO2 will occur.16 Not surprisingly, the inves-
tigators found a significant difference between 
PetCO2 and PaCO2 levels among patients with res-
piratory disease but not among those without it. 
Although this was statistically significant, most of 
the distribution values of the PetCO2 bias were 
within the limits of agreement by the Bland-Altman 
analysis. Despite these concerns, there was an 
excellent correlation between PetCO2 and PaCO2 
among the patients with respiratory disease.
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However, this study also has some limitations: 
(1) small sample size, and (2) the heterogeneity of 
the population studied, which included different 
gestational ages, birth weights, and types of lung 
disease. To clarify the correlation between PetCO2 
and PaCO2 among different study populations and 
in response to diverse therapies, further study is 
needed. Before that, we still have to be cautious in 
applying this clinical technology for management 
of neonatal patients.
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